Combination of Irinotecan and Temozolomide in Children With Brain Tumors

Mise à jour : Il y a 4 ans
Référence : NCT00404495

Femme et Homme

Extrait

This study will assess the rate of objective confirmed tumor response of irinotecan in combination with temozolomide in children with recurrent or refractory medulloblastoma and in children with newly diagnosed high-grade glioma.


Critère d'inclusion

  • glioma ,Medulloblastoma


Liens